BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10968363)

  • 1. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
    Stange T; Kettmann U; Holzhausen HJ
    Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
    Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
    Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of the ectopeptidases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26: immunoultrastructural topographic localization on different types of cultured cells.
    Stange T; Kettmann U; Holzhausen HJ; Riemann D
    Acta Histochem; 1998 Apr; 100(2):157-69. PubMed ID: 9587627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
    Kehlen A; Göhring B; Langner J; Riemann D
    Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.
    Varona A; Blanco L; López JI; Gil J; Agirregoitia E; Irazusta J; Larrinaga G
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F780-8. PubMed ID: 16985214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of three microvillar enzymes along the small intestinal crypt-villus axis.
    Hansen GH; Niels-Christiansen LL; Poulsen MD; Norén O; Sjöström H
    J Submicrosc Cytol Pathol; 1994 Oct; 26(4):453-60. PubMed ID: 7820811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts.
    Sorrell JM; Brinon L; Baber MA; Caplan AI
    Arch Dermatol Res; 2003 Aug; 295(4):160-8. PubMed ID: 12861419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
    Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
    Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polarized membrane expression of brush-border hydrolases in primary cultures of kidney proximal tubular cells depends on cell differentiation and is induced by dexamethasone.
    Ronco P; Antoine M; Baudouin B; Geniteau-Legendre M; Lelongt B; Chatelet F; Verroust P; Vandewalle A
    J Cell Physiol; 1990 Nov; 145(2):222-37. PubMed ID: 1978836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of peptidase activity on clear cell renal cell carcinoma survival.
    Larrinaga G; Blanco L; Sanz B; Perez I; Gil J; Unda M; Andrés L; Casis L; López JI
    Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1584-91. PubMed ID: 23019229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
    van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
    Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum dipeptidyl peptidase IV activity in patients with chronic tonsillitis.
    Vlahović P; Avramović V; Stanković M; Savić S; Todorović M
    Ann Clin Biochem; 2007 Jan; 44(Pt 1):70-4. PubMed ID: 17270095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level.
    van Leer EH; Bruijn JA; Prins FA; Hoedemaeker PJ; de Heer E
    Lab Invest; 1993 May; 68(5):550-6. PubMed ID: 8098785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
    Riemann D; Kehlen A; Langner J
    Clin Exp Immunol; 1995 May; 100(2):277-83. PubMed ID: 7743667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of aminopeptidase N/CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages.
    Riemann D; Kehlen A; Thiele K; Löhn M; Langner J
    J Immunol; 1997 Apr; 158(7):3425-32. PubMed ID: 9120303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in dipeptidyl peptidase activities in cultured human carcinoma cells.
    Komatsu M; Urade M; Yamaoka M; Fukasawa K; Harada M
    J Natl Cancer Inst; 1987 May; 78(5):863-8. PubMed ID: 2883339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
    Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma.
    Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M
    Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.